With high percentage of vaccination in U.S. and Canada, Ocugen has a limited addressable market. With the company still waiting for official FDA approval for the Covaxin, it's advisable for investors to stay away. More
Articles
Vita Coco Could Be Undervalued If Its Q3 Sales Exceed Forecasts
COCO stock could be at full value or even undervalued depending on how well its Q3 sales and future revenue prospects land. More
Bitcoin Miner Greenidge Generation Is Too Speculative to Truly Trust Yet
Greenidge Generation has been a fiasco for investors since its recent reverse split. However, GREE stock could rebound as it has a decent business plan. More
Is ElectraMeccanica Vehicles Stock a Viable Investment?
Electrameccanica began deliveries of its innovative autocycle, but SOLO stock may be stuck in neutral until investors see how it's received. More
Vinco Ventures Is Only for Investors With Extreme Risk Tolerance
BBIG is doing well because the stock deals with all the things millennials like. Despite its focus on tech, the real issue is sustainability. More
Greenidge Generation Is a Cautious Buy After a Steep Post-Merger Drop
GREE stock is suffering from the inevitable post-merger dip. However, it will recover as Bitcoin continues to gain in both price and utility. More
